PMID: 9539789May 16, 1998Paper

Breakers of advanced glycation end products restore large artery properties in experimental diabetes

Proceedings of the National Academy of Sciences of the United States of America
B H WolffenbuttelB I Levy

Abstract

Glucose and other reducing sugars react with proteins by a nonenzymatic, posttranslational modification process called nonenzymatic glycation. The formation of advanced glycation end products (AGEs) on connective tissue and matrix components accounts largely for the increase in collagen crosslinking that accompanies normal aging and which occurs at an accelerated rate in diabetes, leading to an increase in arterial stiffness. A new class of AGE crosslink "breakers" reacts with and cleaves these covalent, AGE-derived protein crosslinks. Treatment of rats with streptozotocin-induced diabetes with the AGE-breaker ALT-711 for 1-3 weeks reversed the diabetes-induced increase of large artery stiffness as measured by systemic arterial compliance, aortic impedance, and carotid artery compliance and distensibility. These findings will have considerable implications for the treatment of patients with diabetes-related complications and aging.

References

Feb 1, 1992·Diabetologia·M Z Gilcrease, R L Hoover
Jan 1, 1985·Journal of Cardiovascular Pharmacology·B I LevyM E Safar
Apr 1, 1988·Experimental and Molecular Pathology·A S Reddi
Sep 1, 1985·Journal of Pharmacological Methods·J BenessianoJ B Michel
May 19, 1988·The New England Journal of Medicine·M BrownleeH Vlassara
Apr 1, 1988·Diabetes·R G SpanheimerV Stumpf
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jul 18, 1996·Nature·K Drickamer
Nov 1, 1996·The Biochemical Journal·H M RaabeP K Müller
Jan 21, 1997·Circulation·J Grotta

❮ Previous
Next ❯

Citations

Oct 19, 2007·Zeitschrift für Gerontologie und Geriatrie·N NassA Simm
Jun 17, 2011·Zeitschrift für Gerontologie und Geriatrie·A Simm
Sep 13, 2011·Amino Acids·Ross Milne, Seymour Brownstein
Mar 8, 2006·Biomechanics and Modeling in Mechanobiology·Ryan W Kobs, Naomi C Chesler
May 24, 2003·Current Diabetes Reports·Nathaniel Winer, James R Sowers
Feb 7, 2004·Current Diabetes Reports·Melpomeni PeppaHelen Vlassara
Jun 6, 2007·Current Diabetes Reports·Helen Vlassara, Gary Striker
Nov 8, 2006·Current Hypertension Reports·Georgia Soldatos, Mark Emmanuel Cooper
Sep 18, 2007·Cell Biochemistry and Biophysics·Sudesh VasdevPawan Singal
Nov 12, 2003·Life Sciences·Peter CelecIngrid Jurkovicová
Mar 21, 2003·Archives of Biochemistry and Biophysics·Shengzu YangJohn W Baynes
May 29, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Cyriel J A L MentinkBruce H R Wolffenbuttel
Jul 2, 2003·Experimental and Molecular Pathology·Alan W Stitt
Apr 27, 2001·Mechanisms of Ageing and Development·A J Bailey
Sep 15, 2001·Mechanisms of Ageing and Development·M L BurgessH L Hedrick
Sep 3, 2002·Journal of the American College of Cardiology·Bronwyn A KingwellAnthony M Dart
Nov 21, 2001·Current Opinion in Pharmacology·R E GilbertR C Atkins
May 26, 2011·Nature Reviews. Endocrinology·Helen Vlassara, Gary E Striker
Mar 22, 2002·Journal of Internal Medicine·H Vlassara, M R Palace
Jan 12, 2002·Kidney International·Eric BoulangerPhilippe Dequiedt
Nov 20, 2002·Seminars in Dialysis·Jose A Diaz-Buxo
Jun 28, 2003·Neurotoxicity Research·V Prakash ReddyMark A Smith
May 7, 2009·Rejuvenation Research·Johan Svantesson Sjöberg, Sven Bulterijs
Nov 29, 2012·Rejuvenation Research·Taehan Kim, David A Spiegel
Jun 29, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·R WeindruchS R Spindler
Mar 21, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Yan GuoYun-lin Cheng
Apr 12, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jehyun ParkHunjoo Ha
Aug 13, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francis VerbekeRaymond Vanholder
Sep 10, 2003·Current Opinion in Rheumatology·Nicole VerzijlJeroen DeGroot
Feb 22, 2002·Current Opinion in Nephrology and Hypertension·Karin Jandeleit-Dahm, Mark E Cooper
Apr 20, 2006·Clinical and Experimental Pharmacology & Physiology·Pon Velayutham Anandh BabuChennam Srinivasulu Shyamaladevi
Mar 30, 2007·Diabetes, Obesity & Metabolism·N Ahmed, P J Thornalley
May 3, 2012·Seminars in Dialysis·Sandeep K MallipattuJaime Uribarri
May 13, 2010·American Journal of Physiology. Endocrinology and Metabolism·Xiao-Liang WangXin-Liang Ma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.